BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31662196)

  • 1. Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?
    Gómez-Ramírez J; Gómez-Valdazo A; Luengo P; Porrero B; Osorio I; Rivas S
    Am J Surg; 2020 Jan; 219(1):150-153. PubMed ID: 31662196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
    Gómez-Ramírez J; Mihai R
    Langenbecks Arch Surg; 2017 Nov; 402(7):1103-1108. PubMed ID: 28823005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
    Chertok Shacham E; Maman N; Lazareva T; Masalha R; Mahagna L; Sela G; Ishay A
    Front Endocrinol (Lausanne); 2023; 14():1152464. PubMed ID: 37065752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
    Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
    Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
    BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
    Wu KCJ; Anpalahan M
    Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism.
    Yu Y; Qiu J; Chuan F; Feng Z; Long J; Zhou B
    Endocr Pract; 2024 Mar; 30(3):231-238. PubMed ID: 38086525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normocalcemic Hyperparathyroidism.
    Corbetta S
    Front Horm Res; 2019; 51():23-39. PubMed ID: 30641527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
    Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
    Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
    Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary hyperparathyroidism - new clinical forms of the disease].
    Zajíčková K
    Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Symptomatic and asymptomatic primary hyperparathyroidism in outpatient care - current issues].
    Šiprová H; Souček M; Fryšák Z; Šipr K
    Vnitr Lek; 2016; 62(10):775-780. PubMed ID: 27900863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR; Sapag Durán A; Zanchetta MB
    Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
    Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What happens to the bone structure after normocalcemic primary hyperparathyroidism surgery?
    Osorio-Silla I; Gómez-Ramírez J; Valdazo-Gómez A; Salido Fernández S; Sánchez García C; Pardo García R
    Surgery; 2022 Apr; 171(4):932-939. PubMed ID: 34736792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperparathyroidism.
    Silva BC; Cusano NE; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
    Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
    Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.